Titre : Tissu sous-cutané

Tissu sous-cutané : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reference Values
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tissu sous-cutané : Questions médicales les plus fréquentes", "headline": "Tissu sous-cutané : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tissu sous-cutané : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-18", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tissu sous-cutané" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tissu conjonctif", "url": "https://questionsmedicales.fr/mesh/D003238", "about": { "@type": "MedicalCondition", "name": "Tissu conjonctif", "code": { "@type": "MedicalCode", "code": "D003238", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A10.165" } } }, "about": { "@type": "MedicalCondition", "name": "Tissu sous-cutané", "alternateName": "Subcutaneous Tissue", "code": { "@type": "MedicalCode", "code": "D040521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jan W Eriksson", "url": "https://questionsmedicales.fr/author/Jan%20W%20Eriksson", "affiliation": { "@type": "Organization", "name": "Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden." } }, { "@type": "Person", "name": "Maria J Pereira", "url": "https://questionsmedicales.fr/author/Maria%20J%20Pereira", "affiliation": { "@type": "Organization", "name": "Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden. maria.pereira@medsci.uu.se." } }, { "@type": "Person", "name": "Babak Razani", "url": "https://questionsmedicales.fr/author/Babak%20Razani", "affiliation": { "@type": "Organization", "name": "Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. brazani@pitt.edu." } }, { "@type": "Person", "name": "Andrea Allmendinger", "url": "https://questionsmedicales.fr/author/Andrea%20Allmendinger", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Development & Supplies Biologics Europe, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland. andrea.allmendinger.aa1@roche.com." } }, { "@type": "Person", "name": "Stefan Fischer", "url": "https://questionsmedicales.fr/author/Stefan%20Fischer", "affiliation": { "@type": "Organization", "name": "Pharmaceutical Development & Supplies Biologics Europe, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36263597", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cen.14836" } }, { "@type": "ScholarlyArticle", "name": "The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors.", "datePublished": "2022-10-27", "url": "https://questionsmedicales.fr/article/36301334", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00392-022-02118-8" } }, { "@type": "ScholarlyArticle", "name": "Value of SGLT-2 inhibitors in the treatment of chronic kidney disease : Clinical and practical implications.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36251099", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00508-022-02096-x" } }, { "@type": "ScholarlyArticle", "name": "Recovering high value-added anthocyanins from blueberry pomace with ultrasound-assisted extraction.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36277868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.fochx.2022.100476" } }, { "@type": "ScholarlyArticle", "name": "Value Coefficient of Polyethylene Fiber Soil Embankment Slope Based on Response Surface Analysis.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36297873", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/polym14204295" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tissus", "item": "https://questionsmedicales.fr/mesh/D014024" }, { "@type": "ListItem", "position": 3, "name": "Tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D003238" }, { "@type": "ListItem", "position": 4, "name": "Tissu sous-cutané", "item": "https://questionsmedicales.fr/mesh/D040521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tissu sous-cutané - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tissu sous-cutané", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tissu sous-cutané", "description": "Comment diagnostiquer une infection du tissu sous-cutané ?\nQuels tests sont utilisés pour évaluer le tissu sous-cutané ?\nQuels signes indiquent une lésion sous-cutanée ?\nComment différencier lipome et kyste sous-cutané ?\nQuels examens pour une tumeur sous-cutanée ?", "url": "https://questionsmedicales.fr/mesh/D040521?mesh_terms=Reference+Values&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tissu sous-cutané", "description": "Quels symptômes d'une inflammation sous-cutanée ?\nComment reconnaître un abcès sous-cutané ?\nQuels signes d'une lésion graisseuse ?\nQuels symptômes d'une cellulite sous-cutanée ?\nQuels symptômes d'une nécrose sous-cutanée ?", "url": "https://questionsmedicales.fr/mesh/D040521?mesh_terms=Reference+Values&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tissu sous-cutané", "description": "Comment prévenir les infections sous-cutanées ?\nQuelles mesures pour éviter les abcès ?\nComment prévenir les complications du tissu sous-cutané ?\nQuelles pratiques pour éviter la cellulite ?\nComment éviter les lipomes ?", "url": "https://questionsmedicales.fr/mesh/D040521?mesh_terms=Reference+Values&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tissu sous-cutané", "description": "Quel traitement pour une infection sous-cutanée ?\nComment traiter un lipome ?\nQuel est le traitement d'un abcès ?\nComment traiter une cellulite ?\nQuels soins pour une lésion sous-cutanée ?", "url": "https://questionsmedicales.fr/mesh/D040521?mesh_terms=Reference+Values&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tissu sous-cutané", "description": "Quelles complications d'une infection sous-cutanée ?\nQuels risques liés à une nécrose sous-cutanée ?\nQuelles complications d'une cellulite ?\nQuels risques d'une lésion sous-cutanée non traitée ?\nQuelles complications après chirurgie du tissu sous-cutané ?", "url": "https://questionsmedicales.fr/mesh/D040521?mesh_terms=Reference+Values&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tissu sous-cutané", "description": "Quels facteurs de risque pour les infections sous-cutanées ?\nQui est à risque de développer des lipomes ?\nQuels facteurs augmentent le risque de cellulite ?\nQuels sont les facteurs de risque de nécrose ?\nQui est à risque de développer des abcès ?", "url": "https://questionsmedicales.fr/mesh/D040521?mesh_terms=Reference+Values&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection du tissu sous-cutané ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique et des tests d'imagerie comme l'échographie peuvent aider." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer le tissu sous-cutané ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie et l'IRM sont couramment utilisés pour évaluer les anomalies." } }, { "@type": "Question", "name": "Quels signes indiquent une lésion sous-cutanée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, douleur et gonflement peuvent indiquer une lésion sous-cutanée." } }, { "@type": "Question", "name": "Comment différencier lipome et kyste sous-cutané ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un lipome est mou et mobile, tandis qu'un kyste est souvent plus ferme et fixe." } }, { "@type": "Question", "name": "Quels examens pour une tumeur sous-cutanée ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie et des examens d'imagerie sont nécessaires pour évaluer une tumeur." } }, { "@type": "Question", "name": "Quels symptômes d'une inflammation sous-cutanée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, douleur et gonflement sont des symptômes d'inflammation." } }, { "@type": "Question", "name": "Comment reconnaître un abcès sous-cutané ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Un abcès se manifeste par une douleur intense, un gonflement et parfois une fièvre." } }, { "@type": "Question", "name": "Quels signes d'une lésion graisseuse ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les lésions graisseuses sont souvent indolores, mobiles et peuvent être palpables." } }, { "@type": "Question", "name": "Quels symptômes d'une cellulite sous-cutanée ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La cellulite se manifeste par une peau rouge, chaude et douloureuse au toucher." } }, { "@type": "Question", "name": "Quels symptômes d'une nécrose sous-cutanée ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La nécrose se présente par une décoloration, une douleur et une perte de sensation." } }, { "@type": "Question", "name": "Comment prévenir les infections sous-cutanées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et traiter rapidement les blessures aide à prévenir les infections." } }, { "@type": "Question", "name": "Quelles mesures pour éviter les abcès ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les blessures cutanées et garder la peau propre peut réduire le risque d'abcès." } }, { "@type": "Question", "name": "Comment prévenir les complications du tissu sous-cutané ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et une bonne gestion des maladies chroniques sont essentiels." } }, { "@type": "Question", "name": "Quelles pratiques pour éviter la cellulite ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hydratation et une alimentation équilibrée peuvent aider à prévenir la cellulite." } }, { "@type": "Question", "name": "Comment éviter les lipomes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode prouvée pour prévenir les lipomes, mais un mode de vie sain est conseillé." } }, { "@type": "Question", "name": "Quel traitement pour une infection sous-cutanée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques sont souvent prescrits pour traiter les infections sous-cutanées." } }, { "@type": "Question", "name": "Comment traiter un lipome ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Un lipome peut être enlevé chirurgicalement si nécessaire, sinon il est souvent inoffensif." } }, { "@type": "Question", "name": "Quel est le traitement d'un abcès ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'abcès nécessite souvent un drainage et peut nécessiter des antibiotiques." } }, { "@type": "Question", "name": "Comment traiter une cellulite ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La cellulite est traitée avec des antibiotiques et des soins locaux pour réduire l'inflammation." } }, { "@type": "Question", "name": "Quels soins pour une lésion sous-cutanée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les soins dépendent de la nature de la lésion, incluant nettoyage et observation." } }, { "@type": "Question", "name": "Quelles complications d'une infection sous-cutanée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les infections peuvent entraîner des abcès, des cellulites ou des septicémies." } }, { "@type": "Question", "name": "Quels risques liés à une nécrose sous-cutanée ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La nécrose peut entraîner des infections graves et nécessiter une amputation dans certains cas." } }, { "@type": "Question", "name": "Quelles complications d'une cellulite ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La cellulite peut évoluer vers des infections plus graves comme la fasciite nécrosante." } }, { "@type": "Question", "name": "Quels risques d'une lésion sous-cutanée non traitée ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les lésions non traitées peuvent s'infecter et entraîner des complications graves." } }, { "@type": "Question", "name": "Quelles complications après chirurgie du tissu sous-cutané ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des infections, des hématomes ou des cicatrices anormales." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections sous-cutanées ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les diabétiques, les personnes immunodéprimées et celles avec des blessures ouvertes sont à risque." } }, { "@type": "Question", "name": "Qui est à risque de développer des lipomes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes obèses et celles ayant des antécédents familiaux de lipomes sont plus à risque." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de cellulite ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le tabagisme et une mauvaise circulation sanguine augmentent le risque." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de nécrose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète, les maladies vasculaires et les traumatismes augmentent le risque de nécrose." } }, { "@type": "Question", "name": "Qui est à risque de développer des abcès ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes avec une peau endommagée ou des maladies cutanées sont plus susceptibles." } } ] } ] }

Sources (10000 au total)

Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.

Adrenalectomy for primary aldosteronism (PA) has been associated with decreased kidney function after surgery. It has been proposed that elimination of excess aldosterone unmasks an underlying failure... Patients with PA referred for adrenal venous sampling (AVS) between May 2011 and August 2021 and who were subsequently offered surgical or medical treatment were eligible for the current study.... A total of 138 patients were included and after AVS 85/138 (61.6%) underwent adrenalectomy while 53/138 (38.4%) were treated with MR-antagonists. In surgically treated patients the estimated glomerula... This retrospective study found that CLS was a strong and independent predictor of a marked reduction of eGFR and an increased risk of hyperkalemia after adrenalectomy in patients with PA....

The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors.

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer; however, at the potential cost of serious adverse events including cardiac injury.... To assess the baseline and longitudinal changes in high sensitivity-Troponin (hs-Tn) in patients treated with pembrolizumab as a potential predictor for the development of major adverse cardiac events... We performed a retrospective analysis of cancer patients treated with pembrolizumab at our center. All participants had baseline measurements of hs-TnI prior to initiation of pembrolizumab (T1), with ... Among 135 patients, the mean age was 72 years, predominantly male (61%). Abnormally elevated hs-TnI at T1 was observed in 7 (5%) patients and emerged as a significant independent predictor for MACE (H... Abnormally elevated baseline and follow-up hs-TnI served as significant independent predictors for MACE, with an increased risk of development being 8-tenfold. Furthermore, elevated baseline hs-TnI sh...

The Value of Metagenomic Next-Generation Sequencing in Leishmaniasis Diagnosis: A Case Series and Literature Review.

Leishmaniasis is a zoonotic disease caused by... The study participants were 7 metagenomic next-generation sequencing (mNGS)-diagnosed patients with leishmaniasis who could not be diagnosed using conventional methods. Clinical data were retrospectiv... A total of 7 patients with recurrent fever, pancytopenia, and significant splenomegaly were included in this study. Only 3 individuals tested positive for rK39. Two individuals, 1 of whom was HIV-posi... mNGS could be used to identify leishmaniasis, particularly in patients who are difficult to diagnose using conventional approaches....

Application Value of Management Model Based on "Zero Tolerance" Concept in Pressure Ulcer Management.

Pressure injuries are the most prevalent health problem worldwide. Improving the quality of hospital pressure injury management is an important indicator to improve the quality of hospital management.... To explore the application value of the management model centered on the concept of "zero tolerance" in the management of pressure ulcers (PU).... The effects of conventional management mode and management mode centered on the concept of "zero tolerance" on PU patients and nursing staff were retrospectively analyzed. The patients were evaluated ... When comparing the conditions of patients under different management modes, it was found that the "zero tolerance" management mode can improve the comfort and quality of life of patients during hospit... Standardized management of PU patients with the concept of "zero tolerance" as the core can improve the health status and quality of life of patients, promote wound healing, and improve the satisfacti...

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.

Cuproptosis is a type of programmed cell death that is involved in multiple physiological and pathological processes, including cancer. We constructed a prognostic cuproptosis-related long non-coding ... RNA-seq and clinical data for AML patients were acquired from The Cancer Genome Atlas (TCGA) database. The cuproptosis-related prognostic lncRNAs were identified by co-expression and univariate Cox re... Five hundred and three lncRNAs related to 19 CRGs in AML samples from the TCGA database were obtained, and 21 differentially expressed lncRNAs were identified based on the 2-year overall survival (OS)... A cuproptosis-related lncRNA signature was established to predict the prognosis and inform on potential therapeutic strategies for AML patients....

Independent prognostic value of left ventricular mass index in patients with light-chain amyloidosis.

Echocardiographic-determined left ventricular mass index (LVMI) provides quantitative information on left-ventricular structure. However, its prognostic value on light-chain (AL) amyloidosis has not b... We included 99 patients with newly diagnosed AL amyloidosis between July 2013 and March 2022. Clinical features and echocardiographic parameters were collected.... LVMI ≥113.4 g/m... LVMI is a reliable prognostic indicator of survival. A cut-off of LVMI (113.4 g/m...